z-logo
open-access-imgOpen Access
Intracerebroventricular Transplantation of Cord Blood-Derived Neural Progenitors in a Child with Severe Global Brain Ischemic Injury
Author(s) -
Sergiusz Jóźwiak,
Aleksandra Habich,
Katarzyna Kotulska,
Anna Sarnowska,
Tomasz Kropiwnicki,
Mirosław Janowski,
Elżbieta Jurkiewicz,
Barbara Łukomska,
Tomasz Kmieć,
Jerzy Walecki,
Marcin Roszkowski,
Mieczysław Litwin,
Tomasz Ołdak,
Dariusz Boruczkowski,
Krystyna DomańskaJanik
Publication year - 2010
Publication title -
cell medicine
Language(s) - English
Resource type - Journals
ISSN - 2155-1790
DOI - 10.3727/215517910x536618
Subject(s) - medicine , transplantation , cord blood , progenitor cell , brain ischemia , neural stem cell , intensive care medicine , ischemia , emergency medicine , anesthesia , stem cell , biology , genetics
Transplantation of neural stem/precursor cells has recently been proposed as a promising, albeit still controversial, approach to brain repair. Human umbilical cord blood could be a source of such therapeutic cells, proven beneficial in several preclinical models of stroke. Intracerebroventricular infusion of neutrally committed cord blood-derived cells allows their broad distribution in the CNS, whereas additional labeling with iron oxide nanoparticles (SPIO) enables to follow the fate of engrafted cells by MRI. A 16-month-old child at 7 months after the onset of cardiac arrest-induced global hypoxic/ischemic brain injury, resulting in a permanent vegetative state, was subjected to intracerebroventricular transplantation of the autologous neutrally committed cord blood cells. These cells obtained by 10-day culture in vitro in neurogenic conditions were tagged with SPIO nanoparticles and grafted monthly by three serial injections (12 × 10(6) cells/0.5 ml) into lateral ventricle of the brain. Neural conversion of cord blood cells and superparamagnetic labeling efficiency was confirmed by gene expression, immunocytochemistry, and phantom study. MRI examination revealed the discrete hypointense areas appearing immediately after transplantation in the vicinity of lateral ventricles wall with subsequent lowering of the signal during entire period of observation. The child was followed up for 6 months after the last transplantation and his neurological status slightly but significantly improved. No clinically significant adverse events were noted. This report indicates that intracerebroventricular transplantation of autologous, neutrally committed cord blood cells is a feasible, well tolerated, and safe procedure, at least during 6 months of our observation period. Moreover, a cell-related MRI signal persisted at a wall of lateral ventricle for more than 4 months and could be monitored in transplanted brain hemisphere.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom